found that reduced methylation levels in the Ephx1 promoter region in PCOS patients activated the expression of Ephx1, thereby inhibiting androgen conversion to E2 and increasing the risk of PCOS (54). The gene discussed is EPHX1; the disease is polycystic ovary syndrome.